Author: Jade Passey

Ben Johnson, 24, from Islington, was diagnosed with a brain tumour in November 2019, after suffering a seizure while at university in London.

Jerome van Leeuwen, age 42, originally from The Netherlands and now living in Fife, Scotland was first diagnosed with a pilocytic astrocytoma brain tumour when he was just two years old, it later returned in his 30s.

The Charity is supporting innovative research at the University of Sheffield, many years on from funding its very first research project there.

Karen Bucknall, 52, from Gloucestershire was diagnosed with a brain tumour in 2021 after she sought an explanation for the headaches she was experiencing throughout her chemotherapy treatment for stage 3 bowel cancer.

In a survey of 1,000 people in the UK, nearly 3 in 4 are unable to name a single symptom of a brain tumour, The Brain Tumour Charity finds.

Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.

Ramona Read was just nine-years-old when she was diagnosed with a low-grade pilocytic astrocytoma in 2021. Her mum, Vicky, shares their story ahead of their appearance on Channel 4’s The Dog House – where families are matched with dogs who hope to find their forever home.

Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.

The government have signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.

Researchers have found the origin of group 3 and 4 childhood medulloblastoma, which could help develop new treatments for children diagnosed with one of the most common forms of cancerous brain tumour.

New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.

A major phase III clinical trial has found that novel treatment DCVax®-L may prolong the lives of people diagnosed with a new or recurrent glioblastoma.

We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).